C-DRUG

C:DRUG - Bright Minds Biosciences Inc. - Common Shares - https://www.brightmindsbio.com

19:56:45 EDT

Sym-X				Last	Vol	$Vol	#Tr	Year Hi-Lo	Last Tr	News	Delay
DRUG - C	·	38.50	0.8	34.41	0.2	6	9	108.00 1.30	09:33:12	May 28	15 min RT 2¢
CSE - C	·	38.50	0.8	34.41	0.05	2	1	108.00 1.30	09:33:12		15 min
CX2 - H				34.41	0.04	1	1		Jul 15		15 min
CXD - D				34.41	0.09	3	7		Jul 17		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - All 9 today

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:30:08	D	35.56	1.15	41	2 RBC	7 TD Sec	E
14:52:03	H	35.95	1.54	40	2 RBC	14 Virtu ITG	E
13:55:45	D	35.75	1.34	3	2 RBC	80 National Bank	E
12:45:31	D	36.11	1.70	17	2 RBC	2 RBC	E
11:19:06	D	35.45	1.04	1	2 RBC	80 National Bank	E
11:05:00	D	35.56	1.15	17	2 RBC	14 Virtu ITG	E
09:46:14	D	36.13	1.72	10	80 National Bank	1 Anonymous	E
09:44:59	D	35.49	1.08	4	1 Anonymous	80 National Bank	E
09:33:12	C	35.50	1.09	50	36 Latimer	124 Questrade	E

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2025-05-28 08:00	C:DRUG	39.26	News Release200	Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
2025-05-20 08:00	C:DRUG	45.23	News Release200	Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025
2025-05-15 19:20	C:DRUG	45.23	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-05-15 19:14	C:DRUG	45.23	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-05-13 18:30	C:DRUG	45.71	News Release200	Bright Minds' DBA/2 mouse study shows no drop attacks
2025-04-28 17:59	C:DRUG	45.05	News Release200	Bright Minds to hold virtual R&D day on May 20
2025-03-04 17:25	C:DRUG	46.32	News Release200	Bright Minds Bio adds five epilepsy researchers to SAB
2025-02-24 06:50	C:DRUG	51.16	News Release200	Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
2025-02-13 16:33	C:DRUG	66.76	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-02-13 16:33	C:DRUG	66.76	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-01-07 14:54	C:DRUG	58.31	News Release200	Bright Minds appoints Collins as chief medical officer
2024-12-30 16:18	C:DRUG	53.24	SEDAR Annual Information Form802	SEDAR Annual Information Form
2024-12-30 16:18	C:DRUG	53.24	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-12-30 16:18	C:DRUG	53.24	SEDAR MD & A815	SEDAR MD & A
2024-11-21 09:00	C:DRUG	46.99	News Release200	Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
2024-11-04 17:56	C:DRUG	69.41	News Release200	Bright Minds closes $35M (U.S.) financing
2024-10-21 16:39	C:DRUG	67.50	News Release200	Bright Minds, Firefly to analyze phase 2 study data
2024-10-18 09:00	C:DRUG	30.00	News Release200	Bright Minds Biosciences arranges $35M (U.S.) financing
2024-10-16 17:28	C:DRUG	39.29	News Release200	Bright Minds finds BMB-201, morphine have like efficacy
2024-10-16 16:52	C:DRUG	39.29	News Release200	Bright Minds to analyze Firefly compound data

Date ET

Symbol

Price

Type

Headline

2025-05-28 08:00

C:DRUG

39.26

News Release

Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference

2025-05-20 08:00

C:DRUG